pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 15·1 min read
save

Remembering Craig Venter: The Complex Legacy Behind the Human Genome Race

May 15, 2026·read at STAT ↗Neutral

Former NIH archivist Zachary Utz reflects on the recent death of Craig Venter, a prominent figure in genomics known for challenging conventional scientific approaches.

Venter’s private company Celera claimed it could outpace the publicly funded Human Genome Project in the late 1990s, prompting a high-profile competition to map the human genome.

While early obituaries highlighted his shotgun sequencing method and the dramatic rivalry, Utz argues that many tributes overlook the broader, messier context of the 13-year effort.

He suggests that the narrative of a simple public-versus-private showdown simplifies the collaborative and contested nature of the project’s ultimate success.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: Tributes to Craig Venter and the genomics race are missing something important”

read at STAT ↗
1,392 words · retrieved May 15
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Johns Hopkins UniversityNational Institutes of Health
topics
Drug Shortage

related stories

  • Sep 17New lawsuit argues NIH violated First Amendment rights of grant applicantsSTAT
  • Sep 14After a brief storm of political headwinds, mRNA is back with strong momentumBioSpace
  • Aug 11IRBs have a problem. Can North Star’s nonprofit model save it?STAT
  • Aug 6Opinion: One year since Kennedy canceled mRNA vaccine projects, science shows how wrong he wasSTAT
  • Jul 31Syphilis spreads while researchers contend with federal constraints and a drug shortageSTAT